AivoCode is developing specific probes that recognize AD signature present in the brain. AivoCode has licensed technology from Sanford Burnham Prebys Medical Discovery Institute (SBP) to improve delivery of therapeutic or an imaging payload from systemic circulation to the injured part of the brain. AivoCode is developing a first-in-class intravitreal therapeutic to inhibit subretinal fibrosis, a known and unaddressed complication in patients with wet AMD. Alzheimer’s disease (AD) is the most common progressive neurodegenerative disorder associated with aging. These probes can be used for therapeutic delivery and non-invasive detection of early AD. AMD is the most common cause of severe loss of eyesight among people 50 years of age and older.
Keywords
Industries
Where is AivoCode located?
The company AivoCode is located in San Diego, California, United States. It's worth noting that the company may has more corporate locations
How many employees does AivoCode approximately have?
As of the latest available information AivoCode has around 1-10 employees worldwide.
When was AivoCode founded?
AivoCode was founded in 2016
In which industries does AivoCode mainly work?
The company AivoCode has it's main focus in the industries of Biotechnology, Science and Engineering, Health Care
ADM Diagnostics
United States
2010
Vitamin AI
Belgium
11-50 Employees
2017
MacuLogix
United States
51-100 Employees
2004
ADix
Sweden
1-10 Employees
2019
Bottneuro
Switzerland
11-50 Employees
2021
Alzheon
United States
11-50 Employees
2013
Salutaris Medical Devices
United States
1-10 Employees
2008
SiNOPSEE Therapeutics
Philippines
Topics which have been searched by others and may be interesting for you:
